110 Canal Street, 4th Floor
-
MetCura is a product focused company building a pipeline of competitive first-in-class and best-in-class oral antibacterial and antiviral therapeutics with limited treatment options.
-
Kong's Pharmaceutical Company specializes in creating endocrine and oncology drugs using small moleculuar compounds to facilitate the recovery process. Their research focuses on developing cutting-edge solutions to address critical health challenges, emphasizing efficacy and safety in every project.
-
EmergingDx was founded on a mission to invent, develop and commercialize emerging technologies and products that can improve the quality of the human condition and also make positive impact on environment and society. EmergingDx implements proven best practices and innovative approaches in the transition of new technologies to the marketplace.
-
Gel4Med is a developmental stage company focused at utilizing its biosynthetic materials platform technology as a first-in-class modality in solving unmet clinical needs for soft tissue repair and regenerative medicine. In 2023, the company anticipates launching its first clinical stage product line directed at biosurgery in wound care.
-
Corti Therapeutics is a seed-stage biotechnology company focusing on developing the next generation of lipid nanoparticle technology for selective and efficient extrahepatic delivery. Our technology has tunable cell selectivity and high developability. We are founded by industry leaders.
-
Canal Biosciences specializes in NGS Product Development with focuses on liquid biopsy and precision medicine.
Wannalancit Mills, 600 Suffolk St Suite 250
-
EnVision Endoscopy is a medical device startup dedicated to addressing the clinical needs for endoscopic surgeries with innovative solutions. Their mission is to provide best solution that helps patients, providers, payers, and policymakers. With a track record of innovation and launching innovative medical devices, their team is dedicated to improve patient’s lives and reduce cost of healthcare with less invasive endoluminal endoscopic procedures.
-
Enquyst Technologies is a biotechnology company that is disrupting the way that biological drugs are manufactured. We have developed next-generation biomanufacturing technology solutions to enable continuous manufacturing and to give the growing diversity of life-changing and curative treatments a viable path to the clinic with affordable costs.